Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions
NCT00616863
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class
Conditions
Epilepsy
Seizures
Interventions
DRUG:
Oxcarbazepine
Sponsor
Roxane Laboratories